1.山东第二医科大学,生命科学与技术学院,山东潍坊
2.山东第二医科大学,基础医学院,山东潍坊
3.四川省第二退伍军人医院心理健康服务中心,四川成都
Wang Yingshuai,E-mail: yingshuaiwang1987@163.com
Yang Nana,E-mail: benben1980@126.com
Received:01 April 2026,
Revised:2026-07-30,
Accepted:03 August 2026,
Published:15 September 2026
移动端阅览
左晓飞,范华菊,吴倩盈,等.硼化镁纳米颗粒通过上调BDNF减轻海马神经元及突触损伤改善糖尿病并发抑郁症小鼠行为和脑结构异常[J].陆军军医大学学报,2026,48(17):2440-2452.DOI:,10.16016/j.2097-0927.202604004.
Zuo X F,Fan H J,Wu Q Y,,et al.Magnesium diboride nanoparticles alleviate hippocampal neurons and synapses by upregulating BDNF to improve behavioral and brain structural abnormalities in diabetes mellitus mice complicated with depression[J].J Army Med Univ,2026,48(17):2440-2452.DOI:,10.16016/j.2097-0927.202604004.
左晓飞,范华菊,吴倩盈,等.硼化镁纳米颗粒通过上调BDNF减轻海马神经元及突触损伤改善糖尿病并发抑郁症小鼠行为和脑结构异常[J].陆军军医大学学报,2026,48(17):2440-2452.DOI:,10.16016/j.2097-0927.202604004. DOI:
Zuo X F,Fan H J,Wu Q Y,,et al.Magnesium diboride nanoparticles alleviate hippocampal neurons and synapses by upregulating BDNF to improve behavioral and brain structural abnormalities in diabetes mellitus mice complicated with depression[J].J Army Med Univ,2026,48(17):2440-2452.DOI:,10.16016/j.2097-0927.202604004. DOI:
目的
2
糖尿病并发抑郁症(diabetes mellitus complicated with depression,DD)是糖尿病患者常见的精神心理共病,表现为持续情绪低落以及糖代谢紊乱加重,严重影响疾病预后与患者生存质量。本研究通过构建DD小鼠模型,探讨硼化镁(MgB
2
)纳米颗粒对其行为和脑结构的影响。
方法
2
本研究利用扫描电子显微镜、X射线衍射对所制备的MgB
2
纳米颗粒进行表征,利用氢气微电极检测该纳米颗粒在体外以及体内胃、肠组织和血液中的释氢性能,通过动物实验评估其体内安全性。40只7~8周龄雄性C57BL/6J小鼠(体质量18~23 g)按照随机数字表法分为对照(Control)组、模型(DD)组、20 mg/kg MgB
2
组、30 mg/kg MgB
2
组和40 mg/kg MgB
2
组。DD组和3个不同剂量的MgB
2
组小鼠通过一次性腹腔注射链脲佐菌素(streptozotocin,STZ,150 mg/kg),在第5 d测空腹血糖(fasting blood glucose,FBG),若FBG≥11.3 mmol/L则持续喂养7 d,随后连续7 d腹腔注射脂多糖(lipopolysaccharide,LPS,0.5 mg/kg)来构建DD小鼠模型,Control组小鼠注射等剂量的柠檬酸-柠檬酸钠缓冲溶液。DD造模成功后,MgB
2
组小鼠连续灌胃对应剂量的MgB
2
纳米颗粒治疗7 d,其余组小鼠灌胃等体积的生理盐水。末次灌胃治疗24 h后通过行为学实验确定最佳治疗剂量。最佳MgB
2
纳米颗
粒剂量治疗后检测小鼠体质量、血清葡萄糖(glucose,GLU)含量;脑部MRI观察小鼠海马体体积、各向异性分数(fractional anisotropy,FA)和平均弥散系数(mean diffusivity,MD);ELISA检测小鼠海马脑源性神经营养因子(brain-derived neurotrophic factor,BDNF);透射电子显微镜观察海马超微结构的变化。
结果
2
MgB
2
纳米颗粒在酸性条件下具有优异释氢特性,且释放过程均匀稳定。该材料兼具高储氢效能和安全性,可在胃内快速释放,在肠组织中缓慢释放,在血液中维持稳定。在旷场实验中,3个不同剂量的MgB
2
组小鼠在中央区域和外周区域的运动距离和穿格次数较DD组显著增加(
P
<
0.01);在高架十字迷宫实验中,3个不同剂量的MgB
2
组小鼠在开放臂上的停留时间与运动距离较DD组显著增加(
P
<
0.05),在封闭臂上的停留时间显著降低、运动距离较DD组显著增加(
P
<
0.01);在悬尾实验和强迫游泳实验中,3个不同剂量的MgB
2
组小鼠的不动时间较DD组显著缩短(
P
<
0.01)。以上行为学实验结果发现3种剂量的MgB
2
纳米颗粒组间疗效相当,因此选择20 mg/kg作为MgB
2
纳米颗粒的最佳治疗剂量。与DD组相比,MgB
2
纳米颗粒能够有效增加小鼠的体质量[(21.85±1.24)
vs
(19.30±1.20)g,
P
<
0.01]、海马体积[(3.77±0.68)
vs
(2.63±0.47)mm
3
,
P
<
0.01]、BDNF[(2 295.78±259.47)
vs
(1 913.69±262.05)pg/mL,
P
<
0.05]和FA(左侧:0.23±0.03
vs
0.16±0.02;右侧:0.22±0.04
vs
0.15±0.02,
P
<
0.01),降低血清GLU含量[(25.97±4.66)
vs
(38.25±8.42)mmol/L,
P
<
0.01]和MD[左侧:(5.11±0.09)×10
-4
vs
(5.42±0.23)×10
-4
mm
2
/s;右侧:(5.19±0.45)×10
-4
vs
(5.60±0.27)×10
-4
mm
2
/s,
P
<
0.05],使得海马神经元核膜完整、核内染色质较均匀,细胞器较丰富,海马突触数量增加(5.33±1.22
vs
3.56±1.50,
P
<
0.05),突触间隙增加[(21.66±2.72)
vs
(17.23±2.69)nm,
P
<
0.01],结构较为清晰。
结论
2
MgB
2
纳米颗粒通过上调BDNF水平,减少对海马神经元和突触的损伤,从而改善DD小鼠的行为和脑结构异常。
Objective
2
Diabetes mellitus complicated with depression (DD) is a common psychiatric comorbidity in diabetic patients
characterized by persistent low mood and disordered glucose metabolism
which severely impacts di
sease prognosis and patient's quality of life. This study aims to investigate the effects of magnesium diboride (MgB
2
) nanoparticles on the behavior and brain structure of mice in a mouse model of DD.
Methods
2
Scanning electron microscopy and X-ray diffraction were performed to characterize the prepared MgB
2
nanoparticles
and hydrogen microelectrodes were employed to detect the hydrogen release properties of the nanoparticles
in vitro
and in the gastric
intestinal
and blood tissues in mice.
In vivo
safety was evaluated through animal experiments. Forty male C57BL/6J mice (7 to 8 weeks old
weighing 18 to 23 g) were randomly divided into a Control group
a model (DD) group
and 20
30 and 40 mg/kg MgB
2
groups. The mice in the DD group and the 3 MgB
2
groups were administered a single intraperitoneal injection of streptozotocin (STZ
150 mg/kg)
and fasting blood glucose (FBG) was measured on day 5. If FBG was ≥11.3 mmol/L
the mice were fed continuously for 7 d
followed by consecutive intraperitoneal injections of lipopolysaccharide (LPS
0.5 mg/kg) for 7 d to establish the DD mouse model
while the mice in the Control group were injected with an equal dose of citric acid-sodium citrate buffer. After successful DD modeling
the mice in the MgB
2
groups were intragastrically administered corresponding doses of MgB
2
nanoparticles for 7 consecutive days
while the mice in the other groups were given an equivalent volume of normal saline by gavage. Behavioral tests were performed 24 h after the final administration to determine the optimal therapeutic dose. Following treatment with the optimal dose of MgB
2
nanoparticles
body weight and serum glucose (GLU) levels were measured. Brain MRI scanning was performed to assess hippocampal volume
fractional anisotropy (FA) and mean diffusivity (MD). Hippocampal brain-derived neurotrophic factor (BDNF) levels were measured by ELISA. Ch
anges in hippocampal ultrastructure were observed by transmission electron microscopy.
Results
2
MgB
2
nanoparticles exhibited excellent hydrogen release properties under acidic conditions
with a uniform and stable release process. The nanoparticles possessed both high hydrogen storage capacity and safety
enabling rapid hydrogen release in the stomach
slow release in intestinal tissue
and stable maintenance in the blood. In the open field test
the mice in the 3 MgB
2
groups showed significant increases in the traveled distance and the crossing numbers in both the central and peripheral zones compared with the DD group (
P
<
0.01). In the elevated plus maze test
treatment of MgB
2
nanoparticles resulted in increased time spent and traveled distance on the open arms compared with those in the DD group (
P
<
0.05)
decreased time spent and more traveled distance in the closed arms compared with that in the DD group (
P
<
0.01). In the tail suspension and forced swim tests
the immobility time of mice in the 3 different MgB
2
dose groups was significantly shorter than that of the DD group (
P
<
0.01). These behavioral findings indicated comparable efficacy among the 3 MgB
2
nanoparticle doses; consequently
20 mg/kg was selected as the optimal therapeutic dose. Compared with the DD group
MgB
2
nanoparticles effectively increased body weight [(21.85±1.24)
vs
(19.3±1.20) g
P
<
0.01
]
hippocampal volume [(3.77±0.68)
vs
(2.63±0.47) mm
3
P
<
0.01
]
BDNF expression [(2 295.78±259.47)
vs
(1 913.69±262.05) pg/mL
P
<
0.05
]
and FA (Left side: 0.23±0.03
vs
0.16±0.02; right side: 0.22±0.04
vs
0.15±0.02
P
<
0.01)
while reducing serum GLU levels [(25.97±4.66)
vs
(38.25±8.42) mmol/L
P
<
0.01
]
and MD [Left side: (5.11±0.09)×10
-4
vs
(5.42±0.23)×10
-4
mm
2
/s; right side: (5.19±0.45)×10
-4
vs
(5.60±0.27)×10
-4
mm
2
/s
P
<
0.05
]
. These improvements resulted in intact nuclear membranes in hippocampal neurons
relatively uniform intranuclear chromatin
abundant organelles
increased number of hippocampal synapses (5.33±1.22
vs
3.56±1.50
P
<
0.05)
elevated synaptic cleft width [(21.66±2.72)
vs
(17.23±2.69) nm
P
<
0.01
]
and clearer structural features.
Conclusion
2
MgB
2
nanoparticles improve behavioral and structural abnormalities in the brains of DD mice by upregulating BDNF levels and reducing damage to hippocampal neurons and synapses.
Duncan B B , Magliano D J , Boyko E J . IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050 [J]. Nephrol Dial Transplant , 2025 , 41 ( 1 ): 7 - 9 . DOI: 10.1093/ndt/gfaf177 http://dx.doi.org/10.1093/ndt/gfaf177 .
Yang K , Fang Y Y , He J B , et al . Prevalence and risk factors of depression in patients with diabetes mellitus: a systematic review and meta-analysis [J]. Front Endocrinol , 2025 , 16 : 1660478 . DOI: 10.3389/fendo.2025.1660478 http://dx.doi.org/10.3389/fendo.2025.1660478 .
Toda T , Parylak S L , Linker S B , et al . The role of adult hippocampal neurogenesis in brain health and disease [J]. Mol Psychiatry , 2019 , 24 ( 1 ): 67 - 87 . DOI: 10.1038/s41380-018-0036-2 http://dx.doi.org/10.1038/s41380-018-0036-2 .
Ma Y , Wang M Y , Zhang M Y , et al . Protective effect of Nootkatone against hippocampal injury in diabetes mellitus with depression via PI3K/AKT pathway: Network pharmacology, molecular docking and experimental validation [J]. Eur J Pharmacol , 2026 , 1017 : 178650 . DOI: 10.1016/j.ejphar.2026.178650 http://dx.doi.org/10.1016/j.ejphar.2026.178650 .
Wu S X , Liang X L , Zhu Q Q , et al . Altered hippocampal subfield volumes are associated with memory and executive function in patients with type 2 diabetes mellitus [J]. World J Diabetes , 2025 , 16 ( 7 ): 104424 . DOI: 10.4239/wjd.v16.i7.104424 http://dx.doi.org/10.4239/wjd.v16.i7.104424 .
Sun F F , Shuai Y F , Wang J R , et al . Hippocampal gray matter volume alterations in patients with first-episode and recurrent major depressive disorder and their associations with gene profiles [J]. BMC Psychiatry , 2025 , 25 ( 1 ): 134 . DOI: 10.1186/s12888-025-06562-4 http://dx.doi.org/10.1186/s12888-025-06562-4 .
Barde Y A . The physiopathology of brain-derived neurotrophic factor [J]. Physiol Rev , 2025 , 105 ( 4 ): 2073 - 2140 . DOI: 10.1152/physrev.00038.2024 http://dx.doi.org/10.1152/physrev.00038.2024 .
Zhang K Q , Zhai W H , Ge X L , et al . Targeting BDNF with acupuncture: a novel integrated strategy for diabetes and depression comorbidity [J]. Heliyon , 2023 , 9 ( 12 ): e22798 . DOI: 10.1016/j.heliyon.2023.e22798 http://dx.doi.org/10.1016/j.heliyon.2023.e22798 .
Mather S , Fisher P , Nevitt S , et al . The limited efficacy of psychological interventions for depression in people with type 1 or type 2 diabetes: an individual participant data meta-analysis (IPD-MA) [J]. J Affect Disord , 2022 , 310 : 25 - 31 . DOI: 10.1016/j.jad.2022.04.132 http://dx.doi.org/10.1016/j.jad.2022.04.132 .
Hoogendoorn C J , Krause-Steinrauf H , Uschner D , et al . Emotional distress predicts reduced type 2 diabetes treatment adherence in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) [J]. Diabetes Care , 2024 , 47 ( 4 ): 629 - 637 . DOI: 10.2337/dc23-1401 http://dx.doi.org/10.2337/dc23-1401 .
Zheng M N , Yu H , Xue Y , et al . The protective effect of hydrogen-rich water on rats with type 2 diabetes mellitus [J]. Mol Cell Biochem , 2021 , 476 ( 8 ): 3089 - 3097 . DOI: 10.1007/s11010-021-04145-x http://dx.doi.org/10.1007/s11010-021-04145-x .
Satoh Y , Araki Y , Kashitani M , et al . Molecular hydrogen prevents social deficits and depression- like behaviors induced by low-intensity blast in mice [J]. J Neuropathol Exp Neurol , 2018 , 77 ( 9 ): 827 - 836 . DOI: 10.1093/jnen/nly060 http://dx.doi.org/10.1093/jnen/nly060 .
Shayea A M F , Renno W M , Qabazard B , et al . Neuroprotective effects of a hydrogen sulfide donor in streptozotocin-induced diabetic rats [J]. Int J Mol Sci , 2023 , 24 ( 23 ): 16650 . DOI: 10.3390/ijms242316650 http://dx.doi.org/10.3390/ijms242316650 .
Fan H J , Shi Y H , Liu H Q , et al . Inhalation of H2/O2 (66.7%/33.3%) mitigates depression-like behaviors in diabetes mellitus complicated with depression mice via suppressing inflammation and preventing hippocampal damage [J]. Biomed Pharmacother , 2024 , 180 : 117559 . DOI: 10.1016/j.biopha.2024.117559 http://dx.doi.org/10.1016/j.biopha.2024.117559 .
Nabavi S F , Sobarzo-Sánchez E , Nabavi S M , et al . Bi-3-azaoxoisoaporphine derivatives have antidepressive properties in a murine model of post stroke-depressive like behavior [J]. Curr Neurovasc Res , 2013 , 10 ( 2 ): 164 - 171 . DOI: 10.2174/1567202611310020009 http://dx.doi.org/10.2174/1567202611310020009 .
Yu H L , Deng X Q , Li Y J , et al . N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice [J]. Pharmacol Rep , 2011 , 63 ( 3 ): 834 - 839 . DOI: 10.1016/s1734-1140(11)70596-5 http://dx.doi.org/10.1016/s1734-1140(11)70596-5 .
AbdElmageed R M , Mohammed Hussein S M . Risk of depression and suicide in diabetic patients [J]. Cureus , 2022 , 14 ( 1 ): e20860 . DOI: 10.7759/cureus.20860 http://dx.doi.org/10.7759/cureus.20860 .
杜青 , 赵洪庆 , 王宇红 , 等 . 左归降糖解郁方对糖尿病并发抑郁症模型大鼠海马神经元突触功能可塑性相关蛋白的影响 [J]. 中国现代应用药学 , 2016 , 33 ( 5 ): 521 - 525 . DOI: 10.13748/j.cnki.issn1007-7693.2016.05.001 http://dx.doi.org/10.13748/j.cnki.issn1007-7693.2016.05.001 .
Du Q , Zhao H Q , Wang Y H , et al . Effects of Zuogui Jiangtang Jieyu Fang on synaptic function plasticity in hippocampal neurons of diabetes mellitus with depression model rats [J]. Chin J Mod Appl Pharm , 2016 , 33 ( 5 ): 521 - 525 . DOI: 10.13748/j.cnki.issn1007-7693.2016.05.001 http://dx.doi.org/10.13748/j.cnki.issn1007-7693.2016.05.001 .
Sun B , Jia X Y , Yang F , et al . CREB-mediated generation and neuronal growth regulates the behavioral improvement of geniposide in diabetes-associated depression mouse model [J]. Neurosci Res , 2021 , 165 : 38 - 44 . DOI: 10.1016/j.neures.2020.05.003 http://dx.doi.org/10.1016/j.neures.2020.05.003 .
Furman B L . Streptozotocin-induced diabetic models in mice and rats [J]. Curr Protoc , 2021 , 1 ( 4 ): e78 . DOI: 10.1002/cpz1.78 http://dx.doi.org/10.1002/cpz1.78 .
Lee J W , Lee Y K , Yuk D Y , et al . Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation [J]. J Neuroinflammation , 2008 , 5 : 37 . DOI: 10.1186/1742-2094-5-37 http://dx.doi.org/10.1186/1742-2094-5-37 .
Couch Y , Trofimov A , Markova N , et al . Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice [J]. J Neuroinflammation , 2016 , 13 ( 1 ): 108 . DOI: 10.1186/s12974-016-0572-0 http://dx.doi.org/10.1186/s12974-016-0572-0 .
Yin R , Zhang K L , Li Y M , et al . Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation [J]. Front Immunol , 2023 , 14 : 1181973 . DOI: 10.3389/fimmu.2023.1181973 http://dx.doi.org/10.3389/fimmu.2023.1181973 .
Chong Z Z , Souayah N . Neuroinflammation in diabetic peripheral neuropathy and therapeutic implications [J]. Rev Neurosci , 2025 , 36 ( 7 ): 749 - 762 . DOI: 10.1515/revneuro-2025-0031 http://dx.doi.org/10.1515/revneuro-2025-0031 .
Karakula-Juchnowicz H , Rog J , Juchnowicz D , et al . The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol [J]. Nutr J , 2019 , 18 ( 1 ): 50 . DOI: 10.1186/s12937-019-0475-x http://dx.doi.org/10.1186/s12937-019-0475-x .
Gao Q , Song H , Wang X T , et al . Molecular hydrogen increases resilience to stress in mice [J]. Sci Rep , 2017 , 7 ( 1 ): 9625 . DOI: 10.1038/s41598-017-10362-6 http://dx.doi.org/10.1038/s41598-017-10362-6 .
Zhang Y , Su W J , Chen Y , et al . Effects of hydrogen-rich water on depressive-like behavior in mice [J]. Sci Rep , 2016 , 6 : 23742 . DOI: 10.1038/srep23742 http://dx.doi.org/10.1038/srep23742 .
Maggio N , Segal M . Steroid modulation of hippocampal plasticity: switching between cognitive and emotional memories [J]. Front Cell Neurosci , 2012 , 6 : 12 . DOI: 10.3389/fncel.2012.00012 http://dx.doi.org/10.3389/fncel.2012.00012 .
Hammad H , Shaltout I , Fawzy M M , et al . Brain-derived neurotrophic factor level and gene polymorphism as risk factors for depression in patients with type 2 diabetes mellitus- a case-controlled study [J]. Curr Diabetes Rev , 2025 , 21 ( 4 ): 13 - 20 . DOI: 10.2174/0115733998274778231218145449 http://dx.doi.org/10.2174/0115733998274778231218145449 .
Lenart L , Balogh D B , Lenart N , et al . Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling [J]. Diabetologia , 2019 , 62 ( 8 ): 1501 - 1513 . DOI: 10.1007/s00125-019-4888-z http://dx.doi.org/10.1007/s00125-019-4888-z .
Zhang J C , Yao W , Hashimoto K . Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets [J]. Curr Neuropharmacol , 2016 , 14 ( 7 ): 721 - 731 . DOI: 10.2174/1570159x14666160119094646 http://dx.doi.org/10.2174/1570159x14666160119094646 .
Chen Z W , Gu J P , Lin S S , et al . Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway [J]. J Ethnopharmacol , 2023 , 300 : 115719 . DOI: 10.1016/j.jep.2022.115719 http://dx.doi.org/10.1016/j.jep.2022.115719 .
Wen M Y , Lian Z S , Huang L Q , et al . Magnetic resonance spectroscopy for assessment of brain injury in the rat model of sepsis [J]. Exp Ther Med , 2017 , 14 ( 5 ): 4118 - 4124 . DOI: 10.3892/etm.2017.5034 http://dx.doi.org/10.3892/etm.2017.5034 .
Mueller S G , Schuff N , Yaffe K , et al . Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer’s disease [J]. Hum Brain Mapp , 2010 , 31 ( 9 ): 1339 - 1347 . DOI: 10.1002/hbm.20934 http://dx.doi.org/10.1002/hbm.20934 .
Lee S , Kim T D , Kim R Y , et al . Hippocampal subregional alterations and verbal fluency in the early stage of type 2 diabetes mellitus [J]. Eur J Neurosci , 2021 , 54 ( 10 ): 7550 - 7559 . DOI: 10.1111/ejn.15505 http://dx.doi.org/10.1111/ejn.15505 .
Fotuhi M , Do D , Jack C . Modifiable factors that alter the size of the hippocampus with ageing [J]. Nat Rev Neurol , 2012 , 8 ( 4 ): 189 - 202 . DOI: 10.1038/nrneurol.2012.27 http://dx.doi.org/10.1038/nrneurol.2012.27 .
Sharma S , Brown C E . Microvascular basis of cognitive impairment in type 1 diabetes [J]. Pharmacol Ther , 2022 , 229 : 107929 . DOI: 10.1016/j.pharmthera.2021.107929 http://dx.doi.org/10.1016/j.pharmthera.2021.107929 .
Sharan P , Vellapandian C . Hypothalamic-pituitary-adrenal (HPA) axis: unveiling the potential mechanisms involved in stress-induced Alzheimer’s disease and depression [J]. Cureus , 2024 , 16 ( 8 ): e67595 . DOI: 10.7759/cureus. 67595 http://dx.doi.org/10.7759/cureus.67595 .
Kodl C T , Franc D T , Rao J P , et al . Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function [J]. Diabetes , 2008 , 57 ( 11 ): 3083 - 3089 . DOI: 10.2337/db08-0724 http://dx.doi.org/10.2337/db08-0724 .
Müller H P , Kassubek J . Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing [J]. Front Hum Neurosci , 2024 , 18 : 1378896 . DOI: 10.3389/fnhum.2024.1378896 http://dx.doi.org/10.3389/fnhum.2024.1378896 .
0
Views
8
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
